Journal: bioRxiv
Article Title: A QbD strategy to develop curcumin and siRNA co-loaded lipoplexes to combat osteoarthritis-related inflammation and oxidative stress
doi: 10.1101/2024.11.25.625050
Figure Lengend Snippet: IL-6 mRNA levels were expressed through qRT-PCR (left), and protein levels were quantified using ELISA (right). a&b – primary chondrocytes C28-CA-22-004, c&d – primary chondrocytes C28-CA-22-009, e&f – primary chondrocytes C28-CA-23-004. Positive control (PC), negative control (NC), curcumin-loaded cationic liposomes (Opt-CL), IL-6 and IL-8 siRNA + Curcumin co-loaded lipoplexes (ILsiRNA-CLx), Scramble siRNA + Curcumin co-loaded lipoplexes (SsiRNA-CLx), IL-6 and IL-8 siRNA lipoplexes (ILsiRNA-Lx), Scramble siRNA lipoplexes (SsiRNA-Lx), and IL-6 and IL-8 siRNA with Lipofectamine RNAimax formulation as a standard for transfection and knockdown (ILsiRNA-LR). Results were expressed as mean ± SD of three independent measurements. A one-way ANOVA test with multiple comparisons was performed to analyze the differences between the effects of the treatments (ns, P > 0.05; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001). The graphs were generated using GraphPad Prism 10.2.2.
Article Snippet: For Lipoplexes, IL-6 siRNA (Cat.No: 4390824 - s7313), IL-8 siRNA (Cat.No: 4390824 - s7328), Scramble (negative control) siRNA (Cat.No: 4390843) were obtained from ThermoFisher Scientific (Eugene, USA).
Techniques: Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Positive Control, Negative Control, Liposomes, Formulation, Transfection, Knockdown, Generated